Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-011228
Filing Date
2003-03-31
Accepted
2003-03-31 15:20:01
Documents
11
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2106276z10-k.htm 10-K 735041
3 EXHIBIT 10.32 a2106276zex-10_32.htm EX-10.32 37627
4 EXHIBIT 10.33 a2106276zex-10_33.htm EX-10.33 29267
5 EXHIBIT 10.34 a2106276zex-10_34.htm EX-10.34 18165
6 EXHIBIT 10.35 a2106276zex-10_35.htm EX-10.35 27715
7 EXHIBIT 10.36 a2106276zex-10_36.htm EX-10.36 4796
8 EXHIBIT 10.37 a2106276zex-10_37.htm EX-10.37 305648
9 EXHIBIT 10.38 a2106276zex-10_38.htm EX-10.38 26546
10 EXHIBIT 23.1 a2106276zex-23_1.htm EX-23.1 1747
11 EXHIBIT 99.1 a2106276zex-99_1.htm EX-99.1 2745
12 EXHIBIT 99.2 a2106276zex-99_2.htm EX-99.2 2733
  Complete submission text file 0001047469-03-011228.txt   1194749
Mailing Address
Business Address 6611 DUMBARTON CIRCLE FREMONT CA 94555 5105052100
CIPHERGEN BIOSYSTEMS INC (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31617 | Film No.: 03630053
SIC: 8731 Services-Commercial Physical & Biological Research